Pharsight

Drugs that contain Oxycodone

1. Xtampza Er patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9248195 COLLEGIUM PHARM INC Abuse-deterrent pharmaceutical compositions of opioids and other drugs
Jul, 2023

(11 months ago)

US10525052 COLLEGIUM PHARM INC Abuse-deterrent drug formulations
Jul, 2023

(11 months ago)

US8840928 COLLEGIUM PHARM INC Tamper-resistant pharmaceutical compositions of opioids and other drugs
Jul, 2023

(11 months ago)

US10525053 COLLEGIUM PHARM INC Abuse-deterrent pharmaceutical compositions of opioids and other drugs
Jul, 2023

(11 months ago)

US9763883 COLLEGIUM PHARM INC Abuse-deterrent drug formulations
Jul, 2023

(11 months ago)

US9592200 COLLEGIUM PHARM INC Abuse-deterrent pharmaceutical compositions of opioids and other drugs
Jul, 2023

(11 months ago)

US9044398 COLLEGIUM PHARM INC Abuse-deterrent pharmaceutical compositions of opiods and other drugs
Jul, 2023

(11 months ago)

US8557291 COLLEGIUM PHARM INC Abuse-deterrent pharmaceutical compositions of opioids and other drugs
Mar, 2025

(9 months from now)

US7399488 COLLEGIUM PHARM INC Abuse-deterrent pharmaceutical compositions of opiods and other drugs
Mar, 2025

(9 months from now)

US7771707 COLLEGIUM PHARM INC Abuse-deterrent drug formulations
Mar, 2025

(9 months from now)

US8449909 COLLEGIUM PHARM INC Abuse-deterrent drug formulations
Mar, 2025

(9 months from now)

US8758813 COLLEGIUM PHARM INC Abuse-deterrent drug formulations
Jun, 2025

(11 months from now)

US10004729 COLLEGIUM PHARM INC Tamper-resistant pharmaceutical compositions of opioids and other drugs
Dec, 2030

(6 years from now)

US9682075 COLLEGIUM PHARM INC Tamper-resistant pharmaceutical compositions of opioids and other drugs
Dec, 2030

(6 years from now)

US10668060 COLLEGIUM PHARM INC Tamper-resistant pharmaceutical compositions of opioids and other drugs
Dec, 2030

(6 years from now)

US10646485 COLLEGIUM PHARM INC Process of making stable abuse-deterrent oral formulations
Sep, 2036

(12 years from now)

US9737530 COLLEGIUM PHARM INC Process of making stable abuse-deterrent oral formulations
Sep, 2036

(12 years from now)

US9968598 COLLEGIUM PHARM INC Process of making stable abuse-deterrent oral formulations
Sep, 2036

(12 years from now)

US10188644 COLLEGIUM PHARM INC Process of making stable abuse-deterrent oral formulations
Sep, 2036

(12 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) Apr 26, 2019

Market Authorisation Date: 26 April, 2016

Treatment: Management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate

Dosage: CAPSULE, EXTENDED RELEASE;ORAL

How can I launch a generic of XTAMPZA ER before it's drug patent expiration?
More Information on Dosage

XTAMPZA ER family patents

Family Patents